Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Kathryn Collison
AstraZeneca
Study Chair - Marta Illueca, MD
AstraZeneca
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
San Juan, Puerto Rico
- Research Site
Anaheim, California, United States
- Research Site
Orange, California, United States
- Research Site
San Diego, California, United States
- Research Site
Miami, Florida, United States
- Research Site
Chicago, Illinois, United States
- Research Site
Chapel Hill, North Carolina, United States
- Research Site
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2006
- Primary completion
- —
- Completion
- 31 May 2007
- Last update posted
- 11 Mar 2009
- Registered enrollment
- 90
- Registry id
- NCT00410592
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.